Purchase Order 15B20526P00000021
- Not listed
- The Department of Defense awarded a firm fixed price purchase order to Priority Healthcare Distribution Inc., doing business as Curascript SD Specialty Distribution, for the supply of Uptravi 800 microgram tablets (National Drug Code 66215-0608-06), a cardiovascular agent used in the treatment of pulmonary arterial hypertension. The contract, awarded on December 10, 2025, carries a ceiling value of $22,743.10 and is scheduled for completion by December 10, 2025. The award was made on a lowest...
- This federal contract award was issued by the Department of Veterans Affairs (VA) Veterans Health Administration to Priority Healthcare Distribution Inc. through its Curascript SD Specialty Distribution division. The $175,587.60 firm fixed price purchase order is for the supply of a single line item pharmaceutical product. The contract has no set-aside designation and will be performed at Priority Healthcare's facility in Lake Mary, Florida. As a prime contractor, Priority Healthcare...
- This is a firm fixed-price purchase order awarded by the Federal Correctional Institution Fort Worth, a civilian agency, to Priority Healthcare Distribution Inc., doing business as Curascript SD Specialty Distribution. The $47,436.22 contract is for the supply of specialty pharmaceutical products, including Adempas, Opsumit, Uptravi, and Valchlor, to support the agency's healthcare programs. The contract has an ultimate completion date of May 12, 2025 and was awarded on April 1, 2025. No...
- This federal contract award to Priority Healthcare Distribution Inc., doing business as Curascript SD Specialty Distribution, is for the supply of three brand name pharmaceutical products to the U.S. Department of Justice Federal Bureau of Prisons Federal Medical Center (FMC) Devens. The contract, which has a ceiling value of $37,072.14, calls for the delivery of Uptravi 200mcg tablets, Orenitram 0.25mg extended-release tablets, and Orenitram 1mg extended-release tablets to support patient...
- This $180,028.68 firm fixed price contract was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Priority Healthcare Distribution Inc. through its Curascript SD Specialty Distribution division. The contract is for the delivery of pharmaceutical products, including cardiovascular treatments, corticosteroids, oncology biologics, and specialty drugs, to support patient care programs at VA facilities. As a prime contractor, Priority Healthcare Distribution has...
- This federal contract award was made by the Department of Veterans Affairs (VA) Veterans Health Administration to Priority Healthcare Distribution Inc. through its Curascript SD Specialty Distribution division. The $188,484.48 firm fixed price purchase order is for the delivery of pharmaceuticals to VA facilities, with a completion date of August 20, 2018. As a for-profit prime contractor, Priority Healthcare Distribution has a history of federal contracts to supply medications and specialty...
- This is a firm fixed-price purchase order contract awarded by the Federal Correctional Complex Butner, a civilian agency within the U.S. Department of Justice, to Priority Healthcare Distribution Inc., doing business as Curascript SD Specialty Distribution. The $24,693.12 contract is for the delivery of Opsumit and Adempas medications to treat pulmonary arterial hypertension for federal inmates. The contract has a period of performance through April 21, 2025 and is designated as a total small...
- This is a federal contract award made by the Department of Veterans Affairs (VA) Veterans Health Administration to Priority Healthcare Distribution Inc., a for-profit organization, to supply pharmaceuticals. The contract is a $188,253.95 firm fixed price purchase order for the delivery of various specialty medications to support patient care programs at VA facilities. The contract does not have a small business set-aside designation. As a prime contractor, Priority Healthcare Distribution Inc....
- This is a firm fixed price purchase order contract awarded by the Department of Veterans Affairs Veterans Health Administration to Priority Healthcare Distribution Inc., through its Curascript SD Specialty Distribution division, to provide pharmaceutical products. The contract has a potential value of $183,530.84 and a completion date of September 11, 2019. It is not associated with a larger contract vehicle and does not have a set-aside designation. The contract was awarded on September 4, 2019...
- This federal contract award is for the supply of a Tyvaso DPI (Treprostinil Inhalation Powder) titration kit to the Department of Veterans Affairs Veterans Health Administration. The contract was awarded to Priority Healthcare Distribution Inc., a for-profit organization, through its Curascript SD Specialty Distribution division. The contract has a firm fixed price of $16,010.87 and a completion date of June 21, 2024. The contract does not have a set-aside designation. Priority Healthcare...
Priority Healthcare Distribution Inc., operating through its Curascript SD Specialty Distribution division, has been awarded a firm fixed-price purchase order by the Federal Medical Center Devens (a civilian facility under the Department of Defense) for $22,743.10 to supply Uptravi 600 microgram tablets, a cardiovascular agent used in the treatment of pulmonary arterial hypertension. The contract was evaluated on a lowest price technically acceptable basis with an ultimate completion date of November 24, 2025, and does not include a small business set-aside designation. The place of performance is Lake Mary, Florida, where Priority Healthcare Distribution maintains its principal distribution operations. This award reflects the continuing relationship between Priority Healthcare Distribution and federal agencies for specialized pharmaceutical procurement. The vendor, registered in the System for Award Management since October 2002, has established itself as a critical distributor of high-cost, complex medications to federal medical facilities and healthcare programs, with a portfolio that includes treatments for rare and serious conditions. The contract supports the medical treatment needs of Federal Medical Center Devens and demonstrates the government's reliance on established pharmaceutical distributors to provide timely access to specialized medications for federal beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Funding Only Action | $22.7k | 12/10/25 |